BPC-157 30 Tablets 500mcg

Description

Strength: 500mcg
CAS: 137525-51-0
Chemical Formula: C₆₂H₉₈N₁₆O₂₂
Molecular weight: 1419.5 g/mol
Peptide Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Synonyms: BPC157, Bepecin
Storage: Store in a cool, dry place at controlled room temperature. Protect from light and moisture.
Shelf life: 24 months from the manufacturing date.

BPC-157 (500 mcg) is a synthetic pentadecapeptide whose sequence corresponds to a fragment of a body protection compound originally identified in human gastric juice, and it has been synthesized for controlled laboratory research.

BPC-157 has been studied in experimental models focusing on tissue repair, angiogenesis, musculoskeletal research, and gastrointestinal studies. Research remains preclinical and investigational.

• Purity: High research-grade purity (≥95% typical analytical standard)
• Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
• Molecular formula: C₆₂H₉₈N₁₆O₂₂
• Molecular weight: 1419.5 g/mol
• CAS number: 137525-51-0
• Storage: Store in a cool, dry place; protect from light and moisture
• Stable for up to 24 months under proper storage conditions
• For laboratory research use only

BPC-157 is being researched for its potential role in biological processes related to tissue integrity and repair. Preclinical studies have explored its influence on:

• Collagen regulation
• Extracellular matrix remodeling
• Cardiac and renal tissue research models
• Fibrotic pathway investigation

In laboratory settings, BPC-157 has been studied for its interaction with pathways involved in:

• VEGFR2 and FAK-paxillin signaling
• Growth hormone receptor upregulation in tendon fibroblasts
• NO-pathway modulation

Research remains preclinical and investigational in nature.

In published preclinical studies, BPC-157 has been evaluated primarily in animal research models. Reported experimental dosing has generally included:

• Microgram per kilogram (µg/kg) ranges
• Short- and mid-term administration protocols
• Parenteral and oral experimental delivery methods, depending on the study design

Observed research findings have included modulation of tissue healing markers, vascular response indicators, and structural integrity markers in controlled laboratory settings. These observations are limited to experimental models and are not clinical recommendations. No approved clinical dosing guidelines exist.

• Store at ≤ –20 °C for long-term storage
• Protect from light and moisture
• Avoid repeated exposure to humidity
• Reconstitute using sterile laboratory-grade solvent under aseptic conditions
• Handle using appropriate laboratory protective equipment
• Dispose of materials in accordance with institutional biosafety procedures

References

1. Seiwerth S, Milavic M, Vukojevic J, et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. 2021;12:627533. Published 2021 Jun 29. doi:10.3389/fphar.2021.627533
2. Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014;19(11):19066-19077. Published 2014 Nov 19. doi:10.3390/molecules191119066
3. Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. Published online July 31, 2025. doi:10.1177/15563316251355551
4. Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastroi—ntestinal tract. Curr Pharm Des. 2011;17(16):1612-1632. doi:10.2174/138161211796196954

Compliance Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use.